Finance

Beta
Lists
300760:SHE
Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CN¥144.39
+1.26%
(+1.80) 1D
Jun 5, 3:04:34 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300760...
Open
CN¥143.64
High
CN¥145.47
Low
CN¥142.93
Mkt. cap
175.31B
Avg. vol.
9.63M
Volume
7.80M
Dividend
2.55%
Quarterly dividend
CN¥0.92
Ex-dividend date
May 28, 2026
P/E ratio
22.33
52-wk high
CN¥257.00
52-wk low
CN¥141.88
EPS
CN¥6.47
Shares outstanding
1.21B
No. of employees
21K
Open
CN¥143.64
High
CN¥145.47
Low
CN¥142.93
Mkt. cap
175.31B
Avg. vol.
9.63M
Volume
7.80M
Dividend
2.55%
Quarterly dividend
CN¥0.92
Ex-dividend date
May 28, 2026
P/E ratio
22.33
52-wk high
CN¥257.00
52-wk low
CN¥141.88
EPS
CN¥6.47
Shares outstanding
1.21B
No. of employees
21K
News stories
From sources across the web
Profile
Mindray Bio-Medical Electronics Co., Ltd., simply known as Mindray, is a Chinese multinational health technology company based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer. Wikipedia
About Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CEO-
Employees21.3K
Founded1991
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.51B
9.09B
7.45B
8.35B
Cost of goods sold
3.42B
3.32B
3.70B
3.18B
Cost of revenue
3.42B
3.32B
3.70B
3.18B
Research and development expenses
840.06M
828.27M
1.14B
801.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59B
1.68B
1.91B
1.58B
Operating expense
2.42B
2.53B
3.19B
2.39B
Total operating expenses
5.84B
5.85B
6.89B
5.57B
Operating income
2.66B
3.24B
563.02M
2.78B
Other non operating income
-114.60M
-38.60M
13.79M
-332.20M
EBT including unusual items
2.86B
2.98B
772.35M
2.54B
EBT excluding unusual items
2.83B
3.16B
581.57M
2.57B
Income tax expense
322.54M
403.50M
134.78M
114.81M
Effective tax rate
11.27%
13.52%
17.45%
4.52%
Other operating expenses
-24.16M
-8.48M
90.41M
-9.50M
Net income
2.44B
2.50B
565.73M
2.33B
Net profit margin
28.69%
27.51%
7.60%
27.89%
Earnings per share
2.00
2.07
-
-
Interest and investment income
126.58M
132.38M
125.46M
124.39M
Interest expense
-5.31M
-6.45M
-7.27M
-6.07M
Net interest expenses
121.27M
125.93M
118.19M
118.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.04B
3.57B
951.35M
3.17B
Gain or loss from assets sale
-736.57K
736.57K
-10.72M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more